Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2002;91:979-981
doi: 10.1161/01.RES.0000045654.34731.FF
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eisner, D.A.
Right arrow Articles by Trafford, A.W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eisner, D.A.
Right arrow Articles by Trafford, A.W.
Related Collections
Right arrow Animal models of human disease
Right arrow Calcium cycling/excitation-contraction coupling
Right arrow Heart failure - basic studies
Right arrow Ion channels/membrane transport
(Circulation Research. 2002;91:979.)
© 2002 American Heart Association, Inc.


Editorials

Heart Failure and the Ryanodine Receptor

Does Occam’s Razor Rule?

D.A. Eisner, A.W. Trafford

From the Unit of Cardiac Physiology, Manchester University, Manchester, UK.

Correspondence to D.A. Eisner, Unit of Cardiac Physiology, 1.524 Stopford Bldg, Manchester University, Oxford Rd, Manchester M13 9PT, UK. E-mail eisner@man.ac.uk


Key Words: heart failure • SERCA • hyperphosphorylation


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

In heart failure, the amplitude and rate of decay of both contraction and the underlying systolic Ca2+ transient are reduced. A current debate concerns the mechanism of these alterations of calcium handling. One theory invokes decreased activity of the sarcoplasmic reticulum (SR) Ca2+-ATPase (SERCA)1 while another focuses on alterations in the SR Ca2+ release channel (ryanodine receptor, RyR).2 A significant contribution to this debate is made by Jiang et al3 in this issue of Circulation Research.

Excitation-Contraction Coupling

Calcium that activates contraction comes from two sources: (1) the extracellular fluid, largely via the L-type Ca2+ current (ICa); and (2) the SR, by release through the RyR. Because the latter is generally larger and the amplitude of ICa is not consistently altered in failure (see review4), work has focused on release from the SR. Release occurs via calcium-induced calcium release (CICR) whereby Ca2+ entry increases the probability of opening of a closely apposed RyR (see general reviews5,6). Relaxation requires that [Ca2+]i be lowered by the combined effects of SERCA and Na+-Ca2+ exchange (NCX). The activity of SERCA is depressed by the accessory protein phospholamban and this inhibition is removed by phosphorylation, providing a mechanism whereby sympathetic stimulation can increase SR Ca2+ content and hence Ca2+ release from the SR. Importantly, depression of SERCA activity will not only decrease the amplitude of the Ca2+ transient (by decreasing SR content) but will also directly slow the rate of decay.

Phosphorylation of the RyR

The RyR can be phosphorylated,7 and there is . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
L. M. Blayney, J.-L. Jones, J. Griffiths, and F. A. Lai
A mechanism of ryanodine receptor modulation by FKBP12/12.6, protein kinase A, and K201
Cardiovasc Res, September 2, 2009; (2009) cvp273v2.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
X. H. T. Wehrens, S. E. Lehnart, S. Reiken, R. van der Nagel, R. Morales, J. Sun, Z. Cheng, S.-X. Deng, L. J. de Windt, D. W. Landry, et al.
Enhancing calstabin binding to ryanodine receptors improves cardiac and skeletal muscle function in heart failure
PNAS, July 5, 2005; 102(27): 9607 - 9612.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. J. Lohse, S. Engelhardt, and T. Eschenhagen
What Is the Role of {beta}-Adrenergic Signaling in Heart Failure?
Circ. Res., November 14, 2003; 93(10): 896 - 906.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. M. Bers, D. A. Eisner, and H. H. Valdivia
Sarcoplasmic Reticulum Ca2+ and Heart Failure: Roles of Diastolic Leak and Ca2+ Transport
Circ. Res., September 19, 2003; 93(6): 487 - 490.
[Full Text] [PDF]


Home page
Circ. Res.Home page
S. A. Khan, M. W. Skaf, R. W. Harrison, K. Lee, K. M. Minhas, A. Kumar, M. Fradley, A. A. Shoukas, D. E. Berkowitz, and J. M. Hare
Nitric Oxide Regulation of Myocardial Contractility and Calcium Cycling: Independent Impact of Neuronal and Endothelial Nitric Oxide Synthases
Circ. Res., June 27, 2003; 92(12): 1322 - 1329.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
F. Brette and C. Orchard
T-Tubule Function in Mammalian Cardiac Myocytes
Circ. Res., June 13, 2003; 92(11): 1182 - 1192.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. R. Marks
A Guide for the Perplexed: Towards an Understanding of the Molecular Basis of Heart Failure
Circulation, March 25, 2003; 107(11): 1456 - 1459.
[Full Text] [PDF]